Почетна › Акутна миелоидна леукемија › Калифорнија › Baldwin Park
Клинички испитувања за Акутна миелоидна леукемија во Baldwin Park, CA
40 студии за Акутна миелоидна леукемија бараат учесници на локации во и околу Baldwin Park (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Се регрутираФаза 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · на 4 милји
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Се регрутираФаза 3
- Clinical Trial Site, Duarte · на 4 милји
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Се регрутираФаза 3
- City of Hope, Duarte · на 4 милји
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Се регрутираФаза 3
- City of Hope Comprehensive Cancer Center, Duarte · на 4 милји
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Се регрутираФаза 2
- City of Hope Comprehensive Cancer Center, Duarte · на 4 милји
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Се регрутираФаза 1
- City of Hope National Medical Center, Duarte · на 4 милји
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Се регрутираФаза 1/2Добредојдени се здрави волонтери
- City of Hope, Duarte · на 4 милји
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Се регрутираФаза 1/2
- City of Hope Comprehensive Cancer Center, Duarte · на 4 милји
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Се регрутираФаза 1/2
- City of Hope National Medical Center, Duarte · на 4 милји
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Individualized AML Treatment
Се регрутираНабљудувачка студија
- City of Hope Medical Center, Duarte · на 4 милји
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Се регрутираФаза 2
- City of Hope Medical Center, Duarte · на 4 милји
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Се регрутираФаза 1Добредојдени се здрави волонтери
- City of Hope Medical Center, Duarte · на 4 милји
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Се регрутираФаза 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · на 4 милји
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Се регрутираНабљудувачка студија
- City of Hope, Duarte · на 4 милји
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Се регрутираФаза 2
- City of Hope Medical Center, Duarte · на 4 милји
A Study of Revumenib and Mezigdomide in People With Leukemia
Се регрутираФаза 1/2
- City of Hope Cancer Center (Data collection only), Duarte · на 4 милји
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Се регрутираФаза 1Добредојдени се здрави волонтери
- City of Hope Medical Center, Duarte · на 4 милји
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Се регрутираФаза 2
- City of Hope, Duarte · на 4 милји
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Се регрутираФаза 2Добредојдени се здрави волонтери
- City of Hope Medical Center, Duarte · на 4 милји
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Се регрутираФаза 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · на 4 милји
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Се регрутираФаза 2
- City of Hope Medical Center, Duarte · на 4 милји
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- City of Hope - Duarte, Duarte · на 4 милји
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Се регрутираФаза 1
- City of Hope Medical Center, Duarte · на 4 милји
Study of REM-422 in Patients With AML or Higher Risk MDS
Се регрутираФаза 1
- City of Hope, Duarte · на 4 милји
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Се регрутираФаза 1
- City of Hope National Medical Center, Duarte · на 4 милји
Испитувања за Акутна миелоидна леукемија во други градови
- Houston, TX85 студии
- New York City, NY51 студија
- Boston, MA44 студии
- Seattle, WA41 студија
- Columbus, OH35 студии
- Philadelphia, PA34 студии
- Durham, NC33 студии
- Atlanta, GA31 студија
- Tampa, FL29 студии
- Chicago, IL26 студии
- Portland, OR25 студии
- Washington, DC24 студии
Други студии во Baldwin Park
- Рак на дојка44 студии
- Колоректален карцином37 студии
- Рак на бели дробови со не-мали клетки36 студии
- Рак (сите типови)34 студии
- Рак на простата30 студии
- Метастатски карцином30 студии
- Миелодиспластични синдроми26 студии
- Карцином на јајниците25 студии
- Рак на бели дробови24 студии
- Множен миелом23 студии
- Рак на стомакот22 студии
- Акутна лимфобластна леукемија21 студија
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.